Associate Professor of Medicine
Medicine
Beth Israel Deaconess Medical Center
United States of America
Dr. McDermott is a medical oncologist and clinical investigator with a particular interest in therapies that enhance the immune response to cancer. He has contributed to the rational application of interleukin-2 and biochemotherapy for renal cell carcinoma and melanoma. He is Director of the Cytokine Working Group which has been a major innovator in the field of solid tumor immunotherapy. More recently, he has worked with anti-angiogenic agents and targeted therapeutics for these malignancies. Board certified in Internal Medicine, Medical Oncology and Hematology, Dr. McDermott earned his medical degree from Weill Medical College of Cornell University, completed a residency in internal medicine and a Fellowship in hematology/oncology at Tufts/New England Medical Center. He is an Assistant Professor of Medicine at Harvard Medical School and a member of the editorial board for the Journal of Clinical Oncology.
Bone Marrow Transplantation; Hematologic Malignancies; Renal Cancer; Melanoma